Skip to content
777 Sourcing.

Capability

small molecule aquaporin-9 inhibitor development

Suppliers
1
States & provinces
1
Countries
1

1 small molecule aquaporin-9 inhibitor development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

APOGLYX AB

LUND, LUND

ApoGlyx AB is a Swedish biopharmaceutical company founded in 2015 that develops first-in-class therapies based on aquaporin inhibitors. Its mission is to bring RG210179, a patented first-in-class Aquaporin-9 inhibitor for the treatment of acute pancreatitis, into a clinical development program. The company is located in Lund, within the Medicon Valley region.

drug discoverypreclinical development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list small molecule aquaporin-9 inhibitor development.

Browse all capabilities